US$ 23.22
glp-1 vertigo meds like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk of developing vestibular GLP-1 meds like semaglutide (Ozempic/Wegovy)
Description
Documented History of Failure: This is a big one
doi: 10.1097/MED.0B013E328350A6E1 65 MabilleauGPereiraMChenuC

To further examine the role of the DTC-GSC adhesions in gonadal longevity, we examined its epistasis with elt-3 and pqm-1 in DTC

The scientific literature confirms this pattern

Second, emerging evidence suggests these drugs may also directly interact with inflammatory and immune pathways involved in autoimmune disease meaning their benefits may go beyond weight loss alone
